Primary Appointment

Dual/Joint/Adjunct Appointment

Dr. Sood is Professor and Director of the Blanton-Davis Ovarian Cancer Research Program in the Departments of Gynecologic Oncology and Cancer Biology at the M. D. Anderson Cancer Center. His research is focused in three main areas: 1) development of new strategies for systemic in vivo siRNA delivery using biocompatible nanoparticles; 2) effect of neuroendocrine stress hormones on ovarian cancer growth and progression; and 3) development of novel anti-vascular therapeutic approaches. Dr. Sood has published numerous peer-reviewed articles and has authored and co-authored several book chapters. Dr. Sood has received major recognition for his research accomplishments including the Gynecologic Cancer Foundation/Margaret Greenfield/Carmel Cohen, M.D. "Excellence in Ovarian Cancer Research Award". 

My research is focused in three main areas: 1) Effects of neuroendocrine pathways on ovarian cancer growth and progression. The adverse effects of stress pathways on the immune system have been known for a long time. My laboratory made the novel observation that stress hormones can have direct effects on ovarian cancer cells via beta-adrenergic receptors and promote angiogenesis, tumor growth and metastasis. Ongoing work is focused on dissecting the molecular and biological processes involved in mediating the effects of stress biology on tumor microenvironment. 2) Development of novel anti-vascular therapeutic approaches. Our ongoing studies in this area are focused on understanding the functional significance of key tyrosine kinases such as EphA2 and focal adhesion kinase in tumor angiogenesis. In addition, we are examining the relevance of perivascular cells in protecting tumor-associated endothelial cells.  Based on these findings, we have developed novel strategies for targeting both endothelial cells and pericytes in ovarian cancers. 3) Development of new strategies for systemic in vivo siRNA delivery. The use of siRNA as a method of gene silencing has rapidly become a powerful tool for determining protein function and gene discovery. The extraordinary sequence specificity of siRNA makes it an attractive tool for cancer therapy. We are utilizing nanovectors for highly efficient in vivo delivery of siRNA with the hope of translating this work for clinical applications in the near future. 

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Last updated: 9/14/2009